Invention Grant
- Patent Title: GABAA positive allosteric modulator compounds for treatment of itch and/or dermatitis
-
Application No.: US16950482Application Date: 2020-11-17
-
Publication No.: US11571421B2Publication Date: 2023-02-07
- Inventor: Matthew Toczko , Jed Hubbs
- Applicant: NeuroCycle Therapeutics, Inc.
- Applicant Address: US MA Cambridge
- Assignee: NeuroCycle Therapeutics, Inc.
- Current Assignee: NeuroCycle Therapeutics, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: K&L Gates LLP
- Main IPC: A61K31/5025
- IPC: A61K31/5025 ; A61P17/04 ; A61K9/00 ; A61K31/437 ; A61K31/502
Abstract:
Disclosed herein are GABAA positive allosteric modulators for the treatment of pruritic conditions and dermatitis. Also disclosed herein are formulations comprising the GABAA positive allosteric modulators.
Public/Granted literature
- US20210137924A1 GABAA POSITIVE ALLOSTERIC MODULATOR COMPOUNDS FOR TREATMENT OF ITECH AND/OR DERMATITIS Public/Granted day:2021-05-13
Information query
IPC分类:
